*ST双成：注射用硼替佐米正在生产前准备中，产品还未正式生产上市

Core Viewpoint - The company is preparing for the production of injectable bortezomib, which has not yet been officially launched in the market [1] Group 1: Company Response - The company addressed investor concerns regarding the impact of the original drug (bortezomib) from Johnson & Johnson/Takeda on its operations [1] - The company indicated that injectable bortezomib is currently in the pre-production stage [1] Group 2: Market Position - The company was asked about the market share of other generic drug companies in the local market [1] - The company provided no specific details on its market share in the Australian market [1]